메뉴 건너뛰기




Volumn 69, Issue 7, 2013, Pages 1351-1368

Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity

Author keywords

Amphotericin; Nephrotoxicity; Prevention

Indexed keywords

AMILORIDE; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CISPLATIN; CREATININE; CYCLOSPORIN; GLUCOSE; INTRALIPID; MANNITOL; OSMOTIC DIURETIC AGENT; PLATINUM DERIVATIVE; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; SOYBEAN OIL; SPIRONOLACTONE; VANCOMYCIN;

EID: 84879068575     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1472-1     Document Type: Review
Times cited : (19)

References (103)
  • 2
    • 85012839775 scopus 로고    scopus 로고
    • Amphotericin B-induced nephrotoxicity
    • 10.1016/B978-0-08-046884-6.00818-6
    • Ulozas E (2010) Amphotericin B-induced nephrotoxicity. Compr Toxicol 7:347-357
    • (2010) Compr Toxicol , vol.7 , pp. 347-357
    • Ulozas, E.1
  • 3
    • 0025256091 scopus 로고
    • Amphotericin B: 30 years of clinical experience
    • 2184499 10.1093/clinids/12.2.308 1:STN:280:DyaK3c3jt1aqtg%3D%3D
    • Gallis HA, Drew RH, Pickard WW (1990) Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12:308-329
    • (1990) Rev Infect Dis , vol.12 , pp. 308-329
    • Gallis, H.A.1    Drew, R.H.2    Pickard, W.W.3
  • 4
    • 0029014618 scopus 로고
    • Sodium chloride treatment of amphotericin B nephrotoxicity-standard of care?
    • 7747495 1:STN:280:DyaK2M3ms1egtg%3D%3D
    • Anderson CM (1995) Sodium chloride treatment of amphotericin B nephrotoxicity-standard of care? West J Med 162:313-317
    • (1995) West J Med , vol.162 , pp. 313-317
    • Anderson, C.M.1
  • 5
    • 0035173531 scopus 로고    scopus 로고
    • The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy
    • 11705428 10.1016/S0002-9343(01)00928-7 1:CAS:528:DC%2BD3MXot1OmurY%3D
    • Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH (2001) The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 111:528-534
    • (2001) Am J Med , vol.111 , pp. 528-534
    • Harbarth, S.1    Pestotnik, S.L.2    Lloyd, J.F.3    Burke, J.P.4    Samore, M.H.5
  • 6
    • 0034525028 scopus 로고    scopus 로고
    • Amphotericin B-induced nephrotoxicity: A review
    • 11154026 1:CAS:528:DC%2BD3MXkvVOmtw%3D%3D
    • Fanos V, Cataldi L (2000) Amphotericin B-induced nephrotoxicity: a review. J Chemother 12(6):463-470
    • (2000) J Chemother , vol.12 , Issue.6 , pp. 463-470
    • Fanos, V.1    Cataldi, L.2
  • 7
    • 3543097595 scopus 로고    scopus 로고
    • Amphotericin B nephrotoxicity in children
    • 15218415 10.1097/00043426-200407000-00004
    • Goldman RD, Koren G (2004) Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol 26:421-426
    • (2004) J Pediatr Hematol Oncol , vol.26 , pp. 421-426
    • Goldman, R.D.1    Koren, G.2
  • 8
    • 26444551209 scopus 로고    scopus 로고
    • Drug-induced hypomagnesaemia: Scope and management
    • 16119971 10.2165/00002018-200528090-00003 1:CAS:528:DC%2BD2MXhtFWmsbvN
    • Atsmon J, Dolev E (2005) Drug-induced hypomagnesaemia: scope and management. Drug Saf 28:763-788
    • (2005) Drug Saf , vol.28 , pp. 763-788
    • Atsmon, J.1    Dolev, E.2
  • 9
    • 0025830941 scopus 로고
    • Effect of salt supplementation on amphotericin B nephrotoxicity
    • 1942779 10.1038/ki.1991.214 1:CAS:528:DyaK3MXlt1Knur8%3D
    • Llanos A, Cieza J, Bernardo J et al (1991) Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int 40:302-308
    • (1991) Kidney Int , vol.40 , pp. 302-308
    • Llanos, A.1    Cieza, J.2    Bernardo, J.3
  • 10
    • 0033966980 scopus 로고    scopus 로고
    • Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia
    • 10669191 10.1345/aph.19127 1:CAS:528:DC%2BD3cXptVKktg%3D%3D
    • Wazny LD, Brophy DF (2000) Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. Ann Pharmacother 34:94-97
    • (2000) Ann Pharmacother , vol.34 , pp. 94-97
    • Wazny, L.D.1    Brophy, D.F.2
  • 11
    • 0035282477 scopus 로고    scopus 로고
    • Mortality and costs of acute renal failure associated with amphotericin B therapy
    • 11229835 10.1086/319211 1:CAS:528:DC%2BD3MXislymu70%3D
    • Bates DW, Su L, Yu DT et al (2001) Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 32:686-693
    • (2001) Clin Infect Dis , vol.32 , pp. 686-693
    • Bates, D.W.1    Su, L.2    Yu, D.T.3
  • 12
    • 84867816193 scopus 로고    scopus 로고
    • Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?
    • 22950480 10.1517/14740338.2012.721775 1:CAS:528:DC%2BC38XhsFCgtrfP
    • Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S (2012) Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf 11:969-983
    • (2012) Expert Opin Drug Saf , vol.11 , pp. 969-983
    • Karimzadeh, I.1    Farsaei, S.2    Khalili, H.3    Dashti-Khavidaki, S.4
  • 13
    • 33846292516 scopus 로고    scopus 로고
    • Prevention of acute renal failure
    • 17218591 10.1378/chest.06-1246 1:CAS:528:DC%2BD2sXhs1aksrg%3D
    • Venkataraman R, Kellum JA (2007) Prevention of acute renal failure. Chest 131:300-308
    • (2007) Chest , vol.131 , pp. 300-308
    • Venkataraman, R.1    Kellum, J.A.2
  • 14
    • 81355153909 scopus 로고    scopus 로고
    • Diuretics in acute kidney injury
    • 22099509 10.1016/j.semnephrol.2011.09.007 1:CAS:528:DC%2BC3MXhsV2gsbnF
    • Nigwekar SU, Waikar SS (2011) Diuretics in acute kidney injury. Semin Nephrol 31:523-534
    • (2011) Semin Nephrol , vol.31 , pp. 523-534
    • Nigwekar, S.U.1    Waikar, S.S.2
  • 15
    • 0015291286 scopus 로고
    • The use of mannitol to reduce the nephrotoxicity of amphotericin B
    • 5009568 1:CAS:528:DyaE38XhsV2js7o%3D
    • Hellebusch AA, Salama F, Eadie E (1972) The use of mannitol to reduce the nephrotoxicity of amphotericin B. Surg Gynecol Obstet 134:241-243
    • (1972) Surg Gynecol Obstet , vol.134 , pp. 241-243
    • Hellebusch, A.A.1    Salama, F.2    Eadie, E.3
  • 16
    • 0017297419 scopus 로고
    • Reduction of amphotericin B nephrotoxicity with mannitol
    • 946511 10.1001/jama.1976.03260440047022 1:STN:280:DyaE287kslWlsQ%3D%3D
    • Rosch JM, Pazin GJ, Fireman P (1976) Reduction of amphotericin B nephrotoxicity with mannitol. JAMA 235:1995-1996
    • (1976) JAMA , vol.235 , pp. 1995-1996
    • Rosch, J.M.1    Pazin, G.J.2    Fireman, P.3
  • 17
    • 0016635716 scopus 로고
    • Mitigation of amphotericin B nephrotoxicity by mannitol
    • 1095113 10.1136/bmj.1.5957.550 1:STN:280:DyaE2M7osVOgtg%3D%3D
    • Olivero JJ, Lozano-Mendez J, Ghafary EM, Eknoyan G, Suki WN (1975) Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J 1:550-551
    • (1975) Br Med J , vol.1 , pp. 550-551
    • Olivero, J.J.1    Lozano-Mendez, J.2    Ghafary, E.M.3    Eknoyan, G.4    Suki, W.N.5
  • 18
    • 0017102142 scopus 로고
    • Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys
    • 791105 10.1128/AAC.10.3.555 1:STN:280:DyaE2s%2FktlertQ%3D%3D
    • Bullock WE, Luke RG, Nuttall CE, Bhathena D (1976) Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrob Agents Chemother 10:555-563
    • (1976) Antimicrob Agents Chemother , vol.10 , pp. 555-563
    • Bullock, W.E.1    Luke, R.G.2    Nuttall, C.E.3    Bhathena, D.4
  • 19
    • 0017656335 scopus 로고
    • Improvement of cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model
    • 856436 10.1002/1097-0142(197704)39:4<1357: AID-CNCR2820390402>3.0. CO;2-C 1:CAS:528:DyaE2sXkslynt7c%3D
    • Cvitkovic E, Spaulding J, Bethune V, Martin J, Whitmore WF (1977) Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 39:1357-1361
    • (1977) Cancer , vol.39 , pp. 1357-1361
    • Cvitkovic, E.1    Spaulding, J.2    Bethune, V.3    Martin, J.4    Whitmore, W.F.5
  • 20
    • 0020062969 scopus 로고
    • Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: A southwest oncology group study
    • 6796269 1:STN:280:DyaL38%2FntVWrtQ%3D%3D
    • Al-Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS, Balducci L, McCracken J, Padilla F (1982) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. Cancer Treat Rep 66:31-35
    • (1982) Cancer Treat Rep , vol.66 , pp. 31-35
    • Al-Sarraf, M.1    Fletcher, W.2    Oishi, N.3    Pugh, R.4    Hewlett, J.S.5    Balducci, L.6    McCracken, J.7    Padilla, F.8
  • 21
    • 0023934062 scopus 로고
    • Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients
    • 3290263 10.1136/jcp.41.5.494 1:STN:280:DyaL1c3lslGiuw%3D%3D
    • Smith SR, Galloway MJ, Reilly JT, Davies JM (1988) Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients. J Clin Pathol 41:494-497
    • (1988) J Clin Pathol , vol.41 , pp. 494-497
    • Smith, S.R.1    Galloway, M.J.2    Reilly, J.T.3    Davies, J.M.4
  • 22
    • 0034916315 scopus 로고    scopus 로고
    • The effect of amiloride on amphotericin B-induced hypokalaemia
    • 11418519 10.1093/jac/48.1.109 1:CAS:528:DC%2BD3MXlsVegtbk%3D
    • Bearden DT, Muncey LA (2001) The effect of amiloride on amphotericin B-induced hypokalaemia. J Antimicrob Chemother 48:109-111
    • (2001) J Antimicrob Chemother , vol.48 , pp. 109-111
    • Bearden, D.T.1    Muncey, L.A.2
  • 23
    • 80052529403 scopus 로고    scopus 로고
    • Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics
    • 10.1111/j.1751-7176.2011.00511.x 1:CAS:528:DC%2BC3MXhsVWjsL3I
    • Epstein M, Calhoun DA (2011) Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich) 13:644-648
    • (2011) J Clin Hypertens (Greenwich) , vol.13 , pp. 644-648
    • Epstein, M.1    Calhoun, D.A.2
  • 24
    • 0035709414 scopus 로고    scopus 로고
    • Spironolactone: Is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
    • 11868798 10.1007/s00228-001-0390-9 1:CAS:528:DC%2BD38Xos12isA%3D%3D
    • Ural AU, Avcu F, Cetin T, Beyan C, Kaptan K, Nazaroglu NK, Yalcin A (2002) Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients? Eur J Clin Pharmacol 57:771-773
    • (2002) Eur J Clin Pharmacol , vol.57 , pp. 771-773
    • Ural, A.U.1    Avcu, F.2    Cetin, T.3    Beyan, C.4    Kaptan, K.5    Nazaroglu, N.K.6    Yalcin, A.7
  • 25
    • 78651470720 scopus 로고    scopus 로고
    • Injectable lipid emulsions-advancements, opportunities and challenges
    • 20976577 10.1208/s12249-010-9526-5 1:CAS:528:DC%2BC3cXhs1alu7fK
    • Hippalgaonkar K, Majumdar S, Kansara V (2010) Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech 11:1526-1540
    • (2010) AAPS PharmSciTech , vol.11 , pp. 1526-1540
    • Hippalgaonkar, K.1    Majumdar, S.2    Kansara, V.3
  • 26
    • 0023743895 scopus 로고
    • An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis
    • 3183418 10.1093/infdis/158.5.1065 1:STN:280:DyaL1M%2FjsFKgug%3D%3D
    • Kirsh R, Goldstein R, Tarloff J, Parris D, Hook J, Hanna N, Bugelski P, Poste G (1988) An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis 158:1065-1070
    • (1988) J Infect Dis , vol.158 , pp. 1065-1070
    • Kirsh, R.1    Goldstein, R.2    Tarloff, J.3    Parris, D.4    Hook, J.5    Hanna, N.6    Bugelski, P.7    Poste, G.8
  • 27
    • 0026452250 scopus 로고
    • Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients
    • 1490923 10.1093/jac/30.4.535 1:STN:280:DyaK3s7ks12ntQ%3D%3D
    • Moreau P, Milpied N, Fayette N, Ramée JF, Harousseau JL (1992) Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother 30:535-541
    • (1992) J Antimicrob Chemother , vol.30 , pp. 535-541
    • Moreau, P.1    Milpied, N.2    Fayette, N.3    Ramée, J.F.4    Harousseau, J.L.5
  • 28
    • 0029616313 scopus 로고
    • Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia
    • 8672820 1:CAS:528:DyaK28Xks1CitA%3D%3D
    • Pascual B, Ayestaran A, Montoro JB, Oliveras J, Estibalez A, Julia A, Lopez A (1995) Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia. Ann Pharmacother 29:1197-1201
    • (1995) Ann Pharmacother , vol.29 , pp. 1197-1201
    • Pascual, B.1    Ayestaran, A.2    Montoro, J.B.3    Oliveras, J.4    Estibalez, A.5    Julia, A.6    Lopez, A.7
  • 29
    • 0027478044 scopus 로고
    • Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients
    • 8444659 10.1093/jac/31.1.161 1:STN:280:DyaK3s7os1Ggsw%3D%3D
    • Caillot D, Casasnovas O, Solary E, Chavanet P, Bonnotte B, Reny G, Entezam F, Lopez J, Bonnin A, Guy H (1993) Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. J Antimicrob Chemother 31:161-169
    • (1993) J Antimicrob Chemother , vol.31 , pp. 161-169
    • Caillot, D.1    Casasnovas, O.2    Solary, E.3    Chavanet, P.4    Bonnotte, B.5    Reny, G.6    Entezam, F.7    Lopez, J.8    Bonnin, A.9    Guy, H.10
  • 30
    • 0032497111 scopus 로고    scopus 로고
    • Safety and toxicity of amphotericin B in glucose 5 % or intralipid 20 % in neutropenic patients with pneumonia or fever of unknown origin: Randomised study
    • 10.1136/bmj.317.7155.379
    • Schöffski P, Freund M, Wunder R, Petersen D, Köhne CH, Hecker H, Schubert U, Ganser A (1998) Safety and toxicity of amphotericin B in glucose 5 % or intralipid 20 % in neutropenic patients with pneumonia or fever of unknown origin: randomised study. Br Med J 317:379-384
    • (1998) Br Med J , vol.317 , pp. 379-384
    • Schöffski, P.1    Freund, M.2    Wunder, R.3    Petersen, D.4    Köhne, C.H.5    Hecker, H.6    Schubert, U.7    Ganser, A.8
  • 31
    • 0028212025 scopus 로고
    • A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies
    • 8040124 10.1093/jac/33.3.603 1:STN:280:DyaK2czhsVOjtw%3D%3D
    • Caillot D, Reny G, Solary E, Casasnovas O, Chavanet P, Bonnotte B, Perello L, Dumas M, Entezam F, Guy H (1994) A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies. J Antimicrob Chemother 33:603-613
    • (1994) J Antimicrob Chemother , vol.33 , pp. 603-613
    • Caillot, D.1    Reny, G.2    Solary, E.3    Casasnovas, O.4    Chavanet, P.5    Bonnotte, B.6    Perello, L.7    Dumas, M.8    Entezam, F.9    Guy, H.10
  • 32
    • 0033031249 scopus 로고    scopus 로고
    • Comparison of the toxicity of amphotericin B in 5 % dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients
    • 10348768 1:CAS:528:DyaK1MXjs12nsbw%3D
    • Nucci M, Loureiro M, Silveira F, Casali AR, Bouzas LF, Velasco E, Spector N, Pulcheri W (1999) Comparison of the toxicity of amphotericin B in 5 % dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients. Antimicrob Agents Chemother 43:1445-1448
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1445-1448
    • Nucci, M.1    Loureiro, M.2    Silveira, F.3    Casali, A.R.4    Bouzas, L.F.5    Velasco, E.6    Spector, N.7    Pulcheri, W.8
  • 33
    • 0033059710 scopus 로고    scopus 로고
    • Amphotericin B in children with malignant disease: A comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion
    • 10348763 1:CAS:528:DyaK1MXjs12nsLk%3D
    • Nath CE, Shaw PJ, Gunning R, McLachlan AJ, Earl JW (1999) Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion. Antimicrob Agents Chemother 43:1417-1423
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1417-1423
    • Nath, C.E.1    Shaw, P.J.2    Gunning, R.3    McLachlan, A.J.4    Earl, J.W.5
  • 34
    • 0029030893 scopus 로고
    • Amphotericin B does not mix with fat emulsion
    • 7671046 1:STN:280:DyaK2MvgtV2ntg%3D%3D
    • Trissel LA (1995) Amphotericin B does not mix with fat emulsion. Am J Health Syst Pharm 52:1463-1464
    • (1995) Am J Health Syst Pharm , vol.52 , pp. 1463-1464
    • Trissel, L.A.1
  • 35
    • 0026759768 scopus 로고
    • Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis
    • 10.1136/bmj.305.6859.921 1:STN:280:DyaK3s%2FptFGkug%3D%3D
    • Chavanet PY, Garry I, Charlier N, Caillot D, Kisterman JP, D'Athis M, Portier H (1992) Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. Br Med J 305:921-925
    • (1992) Br Med J , vol.305 , pp. 921-925
    • Chavanet, P.Y.1    Garry, I.2    Charlier, N.3    Caillot, D.4    Kisterman, J.P.5    D'Athis, M.6    Portier, H.7
  • 36
    • 0030821449 scopus 로고    scopus 로고
    • Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate-fat emulsion in HIV-infected patients with oral candidosis
    • 11864156 10.1111/j.1469-0691.1997.tb00282.x 1:CAS:528:DyaK2sXmtVGht74%3D
    • Chavanet P, Clement C, Duong M, Buisson M, D'Athis P, Dumas M, Bonnin A, Portier H (1997) Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate-fat emulsion in HIV-infected patients with oral candidosis. Clin Microbiol Infect 3:455-461
    • (1997) Clin Microbiol Infect , vol.3 , pp. 455-461
    • Chavanet, P.1    Clement, C.2    Duong, M.3    Buisson, M.4    D'Athis, P.5    Dumas, M.6    Bonnin, A.7    Portier, H.8
  • 37
    • 19244362836 scopus 로고    scopus 로고
    • Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis
    • 8879780 10.1093/clinids/23.3.556 1:CAS:528:DyaK28XlvVGgtbc%3D
    • Joly V, Aubry P, Ndayiragide A, Carrière I, Kawa E, Mlika-Cabanne N, Aboulker JP, Coulaud JP, Larouze B, Yeni P (1996) Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis. Clin Infect Dis 23:556-562
    • (1996) Clin Infect Dis , vol.23 , pp. 556-562
    • Joly, V.1    Aubry, P.2    Ndayiragide, A.3    Carrière, I.4    Kawa, E.5    Mlika-Cabanne, N.6    Aboulker, J.P.7    Coulaud, J.P.8    Larouze, B.9    Yeni, P.10
  • 38
    • 9344255433 scopus 로고    scopus 로고
    • Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: Results of a prospective, randomized, controlled study in critically ill patients
    • 8706484 10.1097/00003246-199608000-00007 1:STN:280:DyaK28zit1yksw%3D%3D
    • Sorkine P, Nagar H, Weinbroum A, Setton A, Israitel E, Scarlatt A, Silbiger A, Rudick V, Kluger Y, Halpern P (1996) Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients. Crit Care Med 24:1311-1315
    • (1996) Crit Care Med , vol.24 , pp. 1311-1315
    • Sorkine, P.1    Nagar, H.2    Weinbroum, A.3    Setton, A.4    Israitel, E.5    Scarlatt, A.6    Silbiger, A.7    Rudick, V.8    Kluger, Y.9    Halpern, P.10
  • 39
    • 0032811743 scopus 로고    scopus 로고
    • A randomized prospective trial of amphotericin B lipid emulsion versus dextrose colloidal solution in critically ill patients
    • 10452470 10.1097/00005373-199908000-00020 1:CAS:528:DyaK1MXlslKis78%3D
    • Barquist E, Fein E, Shadick D, Johnson J, Clark J, Shatz D (1999) A randomized prospective trial of amphotericin B lipid emulsion versus dextrose colloidal solution in critically ill patients. J Trauma 47:336-340
    • (1999) J Trauma , vol.47 , pp. 336-340
    • Barquist, E.1    Fein, E.2    Shadick, D.3    Johnson, J.4    Clark, J.5    Shatz, D.6
  • 40
    • 0028641193 scopus 로고
    • Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar
    • 7886778 10.1016/0035-9203(94)90236-4 1:STN:280:DyaK2M7ptlSnuw%3D%3D
    • Thakur CP (1994) Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar. Trans R Soc Trop Med Hyg 88:698-699
    • (1994) Trans R Soc Trop Med Hyg , vol.88 , pp. 698-699
    • Thakur, C.P.1
  • 41
    • 50049110427 scopus 로고    scopus 로고
    • Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar
    • 18664241 10.1111/j.1365-3156.2008.02128.x 1:CAS:528:DC%2BD1cXht1Shtr3I
    • Sundar S, Chakravarty J, Agarwal D, Shah A, Agrawal N, Rai M (2008) Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar. Trop Med Int Health 13:1208-1212
    • (2008) Trop Med Int Health , vol.13 , pp. 1208-1212
    • Sundar, S.1    Chakravarty, J.2    Agarwal, D.3    Shah, A.4    Agrawal, N.5    Rai, M.6
  • 42
    • 66149103635 scopus 로고    scopus 로고
    • Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis
    • 19407109 1:CAS:528:DC%2BD1MXmt1Kjsr8%3D
    • Sundar S, Singh A, Agarwal D, Rai M, Agrawal N, Chakravarty J (2009) Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis. Am J Trop Med Hyg 80:700-703
    • (2009) Am J Trop Med Hyg , vol.80 , pp. 700-703
    • Sundar, S.1    Singh, A.2    Agarwal, D.3    Rai, M.4    Agrawal, N.5    Chakravarty, J.6
  • 43
    • 0030812502 scopus 로고    scopus 로고
    • Reduction in the nephrotoxicity of amphotericin B when administered in 20 % intralipid
    • 22514488 1:STN:280:DC%2BC38rmtFyltA%3D%3D
    • Salama S, Rotstein C (1997) Reduction in the nephrotoxicity of amphotericin B when administered in 20 % intralipid. Can J Infect Dis 8:157-160
    • (1997) Can J Infect Dis , vol.8 , pp. 157-160
    • Salama, S.1    Rotstein, C.2
  • 44
    • 0028908692 scopus 로고
    • Amphotericin B toxicity reduced by administration in fat emulsion
    • 7655134 1:STN:280:DyaK2MzotlOrug%3D%3D
    • Anderson RP, Clark DA (1995) Amphotericin B toxicity reduced by administration in fat emulsion. Ann Pharmacother 29:496-500
    • (1995) Ann Pharmacother , vol.29 , pp. 496-500
    • Anderson, R.P.1    Clark, D.A.2
  • 45
    • 84861525317 scopus 로고    scopus 로고
    • Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis
    • 22491505 10.1093/cid/cis290 1:CAS:528:DC%2BC38XnvVOhtLY%3D
    • Mistro S, Maciel Ide M, de Menezes RG, Maia ZP, Schooley RT, Badaró R (2012) Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis 54:1774-1777
    • (2012) Clin Infect Dis , vol.54 , pp. 1774-1777
    • Mistro, S.1    Maciel Ide, M.2    De Menezes, R.G.3    Maia, Z.P.4    Schooley, R.T.5    Badaró, R.6
  • 46
    • 0029932155 scopus 로고    scopus 로고
    • Amphotericin B is incompatible with lipid emulsions
    • 8833570 1:STN:280:DyaK28vjtVCntw%3D%3D
    • Ericsson O, Hallmen AC, Wikstrom I (1996) Amphotericin B is incompatible with lipid emulsions. Ann Pharmacother 30:298
    • (1996) Ann Pharmacother , vol.30 , pp. 298
    • Ericsson, O.1    Hallmen, A.C.2    Wikstrom, I.3
  • 47
    • 0030007112 scopus 로고    scopus 로고
    • Amphotericin B formulated in a lipid emulsion
    • 8729899 1:CAS:528:DyaK28XislKgsrg%3D
    • Cleary JD (1996) Amphotericin B formulated in a lipid emulsion. Ann Pharmacother 30:409-412
    • (1996) Ann Pharmacother , vol.30 , pp. 409-412
    • Cleary, J.D.1
  • 48
    • 0030979790 scopus 로고    scopus 로고
    • Precipitation of amphotericin B from i.v. fat emulsion
    • 9194992 1:STN:280:DyaK2szjvVCgsA%3D%3D
    • Heide PE (1997) Precipitation of amphotericin B from i.v. fat emulsion. Am J Health Syst Pharm 54:1449
    • (1997) Am J Health Syst Pharm , vol.54 , pp. 1449
    • Heide, P.E.1
  • 49
    • 84879082011 scopus 로고    scopus 로고
    • National Library of Medicine, National Institutes of Health Accessed 4 May 2012
    • National Library of Medicine, National Institutes of Health. Intralipid (soybean oil) emulsion. Available at: http://dailymed.nlm.nih.gov/dailymed/ drugInfo.cfm?id = 6275. Accessed 4 May 2012
    • Intralipid (Soybean Oil) Emulsion
  • 50
    • 35348926847 scopus 로고    scopus 로고
    • Amphotericin B and coccidioidomycosis
    • 17513463 10.1196/annals.1406.019 1:CAS:528:DC%2BD2sXhtlWjsr7L
    • Johnson RH, Einstein HE (2007) Amphotericin B and coccidioidomycosis. Ann N Y Acad Sci 1111:434-441
    • (2007) Ann N y Acad Sci , vol.1111 , pp. 434-441
    • Johnson, R.H.1    Einstein, H.E.2
  • 51
    • 0021922696 scopus 로고
    • In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester
    • 3994345 10.1128/AAC.27.3.302 1:CAS:528:DyaL2MXhslyktbw%3D
    • Kobayashi GS, Little JR, Medoff G (1985) In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester. Antimicrob Agents Chemother 27:302-305
    • (1985) Antimicrob Agents Chemother , vol.27 , pp. 302-305
    • Kobayashi, G.S.1    Little, J.R.2    Medoff, G.3
  • 52
    • 0002056886 scopus 로고
    • Preparationa nd use of liposomes as models of biological membranes
    • D. KornE (eds) 1 Plenum Press New York 10.1007/978-1-4615-7422-4-1
    • BanghamA D, Hill MW, Miller NGA (1974) Preparationa nd use of liposomes as models of biological membranes. In: KornE D (ed) Methods in membrane biology, vol 1. Plenum Press, New York, pp 1-68
    • (1974) Methods in Membrane Biology , pp. 1-68
    • Banghama, D.1    Hill, M.W.2    Miller, N.G.A.3
  • 55
    • 0033046042 scopus 로고    scopus 로고
    • Lipid-based amphotericin B for the treatment of fungal infections
    • 10221369 10.1592/phco.19.4.306.30934 1:CAS:528:DyaK1MXitVSnsLY%3D
    • Slain D (1999) Lipid-based amphotericin B for the treatment of fungal infections. Pharmacotherapy 19:306-323
    • (1999) Pharmacotherapy , vol.19 , pp. 306-323
    • Slain, D.1
  • 56
    • 0021345457 scopus 로고
    • Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells
    • 6696909 10.1016/0005-2736(84)90135-4 1:CAS:528:DyaL2cXhsVCqs7o%3D
    • Mehta R, Lopez-Berestein G, Hopfer R, Mills K, Juliano RL (1984) Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta 770:230-234
    • (1984) Biochim Biophys Acta , vol.770 , pp. 230-234
    • Mehta, R.1    Lopez-Berestein, G.2    Hopfer, R.3    Mills, K.4    Juliano, R.L.5
  • 57
    • 0026043820 scopus 로고
    • Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
    • 1778892 10.1093/jac/28.suppl-B.49 1:CAS:528:DyaK38Xjtl2rtA%3D%3D
    • Proffitt RT, Satorius A, Chiang SM, Sullivan L, Adler-Moore JP (1991) Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 28[Suppl B]:49-61
    • (1991) J Antimicrob Chemother , vol.28 , Issue.SUPPL. B , pp. 49-61
    • Proffitt, R.T.1    Satorius, A.2    Chiang, S.M.3    Sullivan, L.4    Adler-Moore, J.P.5
  • 58
    • 0028266748 scopus 로고
    • Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
    • 8031034 10.1128/AAC.38.4.713 1:CAS:528:DyaK2cXivVSjurc%3D
    • Lee JW, Amantea MA, Francis PA, Navarro EE, Bacher J, Pizzo PA, Walsh TJ (1994) Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother 38:713-718
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 713-718
    • Lee, J.W.1    Amantea, M.A.2    Francis, P.A.3    Navarro, E.E.4    Bacher, J.5    Pizzo, P.A.6    Walsh, T.J.7
  • 59
    • 0028084861 scopus 로고
    • Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B
    • 8192447 10.1128/AAC.38.2.223 1:CAS:528:DyaK2cXhvVantrk%3D
    • Wasan KM, Rosenblum MG, Cheung L, Lopez-Berestein G (1994) Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B. Antimicrob Agents Chemother 38:223-227
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 223-227
    • Wasan, K.M.1    Rosenblum, M.G.2    Cheung, L.3    Lopez-Berestein, G.4
  • 63
    • 0033545538 scopus 로고    scopus 로고
    • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
    • 10072411 10.1056/NEJM199903113401004 1:CAS:528:DyaK1MXhvFOqu7k%3D
    • Walsh TJ, Finberg RW, Arndt C et al (1999) Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 340:764-771
    • (1999) N Engl J Med , vol.340 , pp. 764-771
    • Walsh, T.J.1    Finberg, R.W.2    Arndt, C.3
  • 64
    • 0037118677 scopus 로고    scopus 로고
    • Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS
    • U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group 12118965 10.7326/0003-4819-137-2-200207160-00008 1:CAS:528: DC%2BD38Xmt1aitrc%3D
    • Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE, U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group (2002) Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 137:105-109
    • (2002) Ann Intern Med , vol.137 , pp. 105-109
    • Johnson, P.C.1    Wheat, L.J.2    Cloud, G.A.3    Goldman, M.4    Lancaster, D.5    Bamberger, D.M.6    Powderly, W.G.7    Hafner, R.8    Kauffman, C.A.9    Dismukes, W.E.10
  • 68
    • 1942436895 scopus 로고    scopus 로고
    • Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies-a randomized, controlled trial
    • 15059069 10.1111/j.1600-0609.2004.00239.x
    • Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J (2004) Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies-a randomized, controlled trial. Eur J Haematol 72:342-347
    • (2004) Eur J Haematol , vol.72 , pp. 342-347
    • Subirà, M.1    Martino, R.2    Gómez, L.3    Martí, J.M.4    Estany, C.5    Sierra, J.6
  • 70
    • 33747443131 scopus 로고    scopus 로고
    • Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries
    • Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators 16838223 10.1086/505969
    • Ullmann AJ, Sanz MA, Tramarin A, Barnes RA, Wu W, Gerlach BA, Krobot KJ, Gerth WC, Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators (2006) Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis 43:e29-e38
    • (2006) Clin Infect Dis , vol.43
    • Ullmann, A.J.1    Sanz, M.A.2    Tramarin, A.3    Barnes, R.A.4    Wu, W.5    Gerlach, B.A.6    Krobot, K.J.7    Gerth, W.C.8
  • 71
    • 0031710982 scopus 로고    scopus 로고
    • A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology
    • 9792308 10.1046/j.1365-2141.1998.00934.x 1:CAS:528:DyaK1cXnt1aksLk%3D
    • Clark AD, McKendrick S, Tansey PJ, Franklin IM, Chopra R (1998) A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology. Br J Haematol 103:198-204
    • (1998) Br J Haematol , vol.103 , pp. 198-204
    • Clark, A.D.1    McKendrick, S.2    Tansey, P.J.3    Franklin, I.M.4    Chopra, R.5
  • 72
    • 0034456963 scopus 로고    scopus 로고
    • A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group
    • L Amph/ABLC Collaborative Study Group 11073745 10.1086/317451 1:CAS:528:DC%2BD3MXhsVKhtg%3D%3D
    • Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A, L Amph/ABLC Collaborative Study Group (2000) A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. Clin Infect Dis 31:1155-1163
    • (2000) Clin Infect Dis , vol.31 , pp. 1155-1163
    • Wingard, J.R.1    White, M.H.2    Anaissie, E.3    Raffalli, J.4    Goodman, J.5    Arrieta, A.6
  • 73
    • 0035049295 scopus 로고    scopus 로고
    • Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia
    • 11426524 10.3109/10428190109097650 1:CAS:528:DC%2BD3MXjtVCjtbo%3D
    • Fleming RV, Kantarjian HM, Husni R, Rolston K, Lim J, Raad I, Pierce S, Cortes J, Estey E (2001) Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia. Leuk Lymphoma 40:511-520
    • (2001) Leuk Lymphoma , vol.40 , pp. 511-520
    • Fleming, R.V.1    Kantarjian, H.M.2    Husni, R.3    Rolston, K.4    Lim, J.5    Raad, I.6    Pierce, S.7    Cortes, J.8    Estey, E.9
  • 74
    • 0034861678 scopus 로고    scopus 로고
    • A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations
    • 11560200 10.1592/phco.21.13.1107.34613 1:CAS:528:DC%2BD3MXnt1Wgsbc%3D
    • Cannon JP, Garey KW, Danziger LH (2001) A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations. Pharmacotherapy 21:1107-1114
    • (2001) Pharmacotherapy , vol.21 , pp. 1107-1114
    • Cannon, J.P.1    Garey, K.W.2    Danziger, L.H.3
  • 75
    • 9144238092 scopus 로고    scopus 로고
    • Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
    • 14745876 10.1002/cncr.11936 1:CAS:528:DC%2BD2cXhs1Wrtrw%3D
    • Mattiuzzi GN, Kantarjian H, Faderl S, Lim J, Kontoyiannis D, Thomas D, Wierda W, Raad I, Garcia-Manero G, Zhou X, Ferrajoli A, Bekele N, Estey E (2004) Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer 100:581-589
    • (2004) Cancer , vol.100 , pp. 581-589
    • Mattiuzzi, G.N.1    Kantarjian, H.2    Faderl, S.3    Lim, J.4    Kontoyiannis, D.5    Thomas, D.6    Wierda, W.7    Raad, I.8    Garcia-Manero, G.9    Zhou, X.10    Ferrajoli, A.11    Bekele, N.12    Estey, E.13
  • 76
    • 41149148599 scopus 로고    scopus 로고
    • Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
    • 18224662 10.1002/cncr.23311 1:CAS:528:DC%2BD1cXksFKju7g%3D
    • Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II (2008) Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer 112:1282-1287
    • (2008) Cancer , vol.112 , pp. 1282-1287
    • Hachem, R.Y.1    Boktour, M.R.2    Hanna, H.A.3    Husni, R.N.4    Torres, H.A.5    Afif, C.6    Kontoyiannis, D.P.7    Raad, I.I.8
  • 77
    • 0035665846 scopus 로고    scopus 로고
    • Can we decrease amphotericin nephrotoxicity?
    • 11805538 10.1097/00075198-200112000-00002 1:STN:280: DC%2BD38%2Fotl2iug%3D%3D
    • Costa S, Nucci M (2001) Can we decrease amphotericin nephrotoxicity? Curr Opin Crit Care 7:379-383
    • (2001) Curr Opin Crit Care , vol.7 , pp. 379-383
    • Costa, S.1    Nucci, M.2
  • 78
    • 0034565160 scopus 로고    scopus 로고
    • Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia
    • Johansen HK, Gotzsche PC (2000) Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia. Cochrane Database Syst Rev 2000(3):CD000969
    • (2000) Cochrane Database Syst Rev , vol.2000 , Issue.3
    • Johansen, H.K.1    Gotzsche, P.C.2
  • 79
    • 2542444843 scopus 로고    scopus 로고
    • Amphotericin B for the treatment of systemic fungal infections: Meta-analysis of conventional versus lipid formulations
    • 42nd ICAAC, San Diego, CA, Abstract - 888
    • Macauly SS, Martin JE, Zarnke KB (2002) Amphotericin B for the treatment of systemic fungal infections: meta-analysis of conventional versus lipid formulations. In: Interscience Conf on Antimicrobial Agents and Chemotherapy. 42nd ICAAC, San Diego, CA, Abstract - 888
    • (2002) Interscience Conf on Antimicrobial Agents and Chemotherapy
    • Macauly, S.S.1    Martin, J.E.2    Zarnke, K.B.3
  • 81
    • 1942438527 scopus 로고    scopus 로고
    • Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): A review of the literature
    • 15119986 10.1185/030079904125003179 1:CAS:528:DC%2BD2cXksVSis7c%3D
    • Martino R (2004) Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature. Curr Med Res Opin 20:485-504
    • (2004) Curr Med Res Opin , vol.20 , pp. 485-504
    • Martino, R.1
  • 82
    • 62149098304 scopus 로고    scopus 로고
    • Liposomal amphotericin B: A review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections
    • 19275278 10.2165/00003495-200969030-00010 1:CAS:528:DC%2BD1MXls1yls7w%3D
    • Moen MD, Lyseng-Williamson KA, Scott LJ (2009) Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69:361-392
    • (2009) Drugs , vol.69 , pp. 361-392
    • Moen, M.D.1    Lyseng-Williamson, K.A.2    Scott, L.J.3
  • 84
    • 0031686559 scopus 로고    scopus 로고
    • Lipid formulations of amphotericin B: Clinical efficacy and toxicities
    • 9770163 10.1086/514704 1:CAS:528:DyaK1cXmt1Gkur8%3D
    • Wong-Beringer A, Jacobs RA, Guglielmo BJ (1998) Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 27:603-618
    • (1998) Clin Infect Dis , vol.27 , pp. 603-618
    • Wong-Beringer, A.1    Jacobs, R.A.2    Guglielmo, B.J.3
  • 85
    • 0033852991 scopus 로고    scopus 로고
    • Pulmonary extraction and accumulation of lipid formulations of amphotericin B
    • 10921589 10.1097/00003246-200007000-00056 1:CAS:528:DC%2BD3MXntFKhu7Y%3D
    • Matot I, Pizov R (2000) Pulmonary extraction and accumulation of lipid formulations of amphotericin B. Crit Care Med 28:2528-2532
    • (2000) Crit Care Med , vol.28 , pp. 2528-2532
    • Matot, I.1    Pizov, R.2
  • 87
    • 0008917225 scopus 로고    scopus 로고
    • Pharmacoeconomics of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of persistently febrile neutropenic patients
    • Toronto, CA, Abstract - 506
    • Greenberg RN, Cagnoni PJ, Prendergast MM, Tong KB (2000) Pharmacoeconomics of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of persistently febrile neutropenic patients. In: Interscience Conf on Antimicrobial Agents and Chemotherapy. 40th ICAAC, Toronto, CA, Abstract - 506
    • (2000) Interscience Conf on Antimicrobial Agents and Chemotherapy. 40th ICAAC
    • Greenberg, R.N.1    Cagnoni, P.J.2    Prendergast, M.M.3    Tong, K.B.4
  • 88
    • 0019217687 scopus 로고
    • Adenosine as a possible mediator of metabolic control of glomerular filtration rate
    • 7399032 10.1016/0020-711X(80)90082-8 1:CAS:528:DyaL3cXmtVWqsL8%3D
    • Osswald H, Nabakowski G, Hermes H (1980) Adenosine as a possible mediator of metabolic control of glomerular filtration rate. Int J Biochem 12:263-267
    • (1980) Int J Biochem , vol.12 , pp. 263-267
    • Osswald, H.1    Nabakowski, G.2    Hermes, H.3
  • 89
    • 0020700998 scopus 로고
    • Effect of aminophylline on amphotericin B nephrotoxicity in the dog
    • 6298404 1:CAS:528:DyaL3sXhsFCqtrY%3D
    • Gerkens JF, Heidemann HT, Jackson EK, Branch RA (1983) Effect of aminophylline on amphotericin B nephrotoxicity in the dog. J Pharmacol Exp Ther 224:609-613
    • (1983) J Pharmacol Exp Ther , vol.224 , pp. 609-613
    • Gerkens, J.F.1    Heidemann, H.T.2    Jackson, E.K.3    Branch, R.A.4
  • 90
    • 0020503451 scopus 로고
    • Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat
    • 6646242 10.1007/BF00497021 1:STN:280:DyaL2c%2FmvVahsw%3D%3D
    • Heidemann HT, Gerkens JF, Jackson EK, Branch RA (1983) Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat. Naunyn Schmiedebergs Arch Pharmacol 324:148-152
    • (1983) Naunyn Schmiedebergs Arch Pharmacol , vol.324 , pp. 148-152
    • Heidemann, H.T.1    Gerkens, J.F.2    Jackson, E.K.3    Branch, R.A.4
  • 91
    • 0025248525 scopus 로고
    • Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity
    • 2340862 10.1016/0014-2999(90)90107-H 1:CAS:528:DyaK3cXktVSiu7Y%3D
    • Kuan CJ, Branch RA, Jackson EK (1990) Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity. Eur J Pharmacol 178:285-291
    • (1990) Eur J Pharmacol , vol.178 , pp. 285-291
    • Kuan, C.J.1    Branch, R.A.2    Jackson, E.K.3
  • 92
    • 0025870801 scopus 로고
    • Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058
    • 1675291 1:CAS:528:DyaK3MXksVWgurs%3D
    • Brooks DP, Mitchell MP, Short BG, Ruffolo RR Jr, Nichols AJ (1991) Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058. J Pharmacol Exp Ther 257:1243-1247
    • (1991) J Pharmacol Exp Ther , vol.257 , pp. 1243-1247
    • Brooks, D.P.1    Mitchell, M.P.2    Short, B.G.3    Ruffolo, Jr.R.R.4    Nichols, A.J.5
  • 93
    • 0026500607 scopus 로고
    • Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog
    • 1346161 1:CAS:528:DyaK38Xns1Srtw%3D%3D
    • Nichols AJ, Koster PF, Brooks DP, Ruffolo RRJR (1992) Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog. J Pharmacol Exp Ther 260:269-274
    • (1992) J Pharmacol Exp Ther , vol.260 , pp. 269-274
    • Nichols, A.J.1    Koster, P.F.2    Brooks, D.P.3    Ruffolo, R.4
  • 94
    • 0024338726 scopus 로고
    • Nifedipine and amphotericin B nephrotoxicity in the rat
    • 2739868 10.1159/000185657 1:CAS:528:DyaL1MXit1Gjur4%3D
    • Soupart A, Decaux G (1989) Nifedipine and amphotericin B nephrotoxicity in the rat. Nephron 52:278-280
    • (1989) Nephron , vol.52 , pp. 278-280
    • Soupart, A.1    Decaux, G.2
  • 95
    • 0026648044 scopus 로고
    • Direct amphotericin B-mediated tubular toxicity: Assessments of selected cytoprotective agents
    • 1501413 10.1038/ki.1992.229 1:CAS:528:DyaK38XltVelt7Y%3D
    • Zager RA, Bredl CR, Schimpf BA (1992) Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents. Kidney Int 41:1588-1594
    • (1992) Kidney Int , vol.41 , pp. 1588-1594
    • Zager, R.A.1    Bredl, C.R.2    Schimpf, B.A.3
  • 96
    • 0026195956 scopus 로고
    • Chronic amphotericin B nephrotoxicity in the rat: Protective effect of calcium channel blockade
    • 1:CAS:528:DyaK38XnsFOntg%3D%3D
    • Tolins JP, Raij L (1991) Chronic amphotericin B nephrotoxicity in the rat: protective effect of calcium channel blockade. Am Soc Nephrol 2:98-102
    • (1991) Am Soc Nephrol , vol.2 , pp. 98-102
    • Tolins, J.P.1    Raij, L.2
  • 97
    • 0035111992 scopus 로고    scopus 로고
    • Apoptosis contributes to amphotericin B-induced nephrotoxicity
    • 11181342 10.1128/AAC.45.3.679-685.2001 1:CAS:528:DC%2BD3MXhsFWgt7s%3D
    • Varlam DE, Siddiq MM, Parton LA, Rüssmann H (2001) Apoptosis contributes to amphotericin B-induced nephrotoxicity. Antimicrob Agents Chemother 45:679-685
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 679-685
    • Varlam, D.E.1    Siddiq, M.M.2    Parton, L.A.3    Rüssmann, H.4
  • 98
    • 0030720871 scopus 로고    scopus 로고
    • Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment
    • 9335396 1:CAS:528:DyaK1cXhtVWqsbY%3D
    • Sheikh-Hamad D, Timmins K, Jalali Z (1997) Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 8:1640-1644
    • (1997) J Am Soc Nephrol , vol.8 , pp. 1640-1644
    • Sheikh-Hamad, D.1    Timmins, K.2    Jalali, Z.3
  • 99
    • 0032950473 scopus 로고    scopus 로고
    • N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats
    • 10328471 10.1093/ndt/14.4.923 1:CAS:528:DyaK1MXislOgsbo%3D
    • Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A (1999) N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14:923-929
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 923-929
    • Tariq, M.1    Morais, C.2    Sobki, S.3    Al Sulaiman, M.4    Al Khader, A.5
  • 100
    • 0035854556 scopus 로고    scopus 로고
    • Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats
    • 11470263 10.1016/S0014-2999(01)01130-X 1:CAS:528:DC%2BD3MXltlOht7o%3D
    • Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S (2001) Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol 424:75-83
    • (2001) Eur J Pharmacol , vol.424 , pp. 75-83
    • Mazzon, E.1    Britti, D.2    De Sarro, A.3    Caputi, A.P.4    Cuzzocrea, S.5
  • 101
    • 0034691822 scopus 로고    scopus 로고
    • Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
    • 10900277 10.1056/NEJM200007203430304 1:CAS:528:DC%2BD3cXlsF2jsrs%3D
    • Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
    • (2000) N Engl J Med , vol.343 , pp. 180-184
    • Tepel, M.1    Van Der Giet, M.2    Schwarzfeld, C.3    Laufer, U.4    Liermann, D.5    Zidek, W.6
  • 103
    • 67649991195 scopus 로고    scopus 로고
    • Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine
    • 19414577 10.1128/AAC.00001-09 1:CAS:528:DC%2BD1MXotlajsL4%3D
    • Odabasi Z, Karaalp A, Cermik H, Mohr J, Tigen ET, Koc M, Korten V (2009) Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine. Antimicrob Agents Chemother 53:3100-3102
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3100-3102
    • Odabasi, Z.1    Karaalp, A.2    Cermik, H.3    Mohr, J.4    Tigen, E.T.5    Koc, M.6    Korten, V.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.